Lampe, Kyle
Primary Appointment
Associate Professor of Chemical Engineering, Chemical Engineering
Education
- BS, Chemical Engineering, Missouri University of Science and Technology
- PhD, Chemical Engineering, University of Colorado, Boulder
- Postdoc, Materials Science and Engineering, Stanford University
Contact Information
P.O. Box 400741, 102 Engineers' Way
202 Wilsdorf Hall
Charlottesville, VA 22904
Telephone: (434) 982-6921
Fax: (434) 982-5358
Email: lampe@virginia.edu
Website: https://engineering.virginia.edu/lampe-biomaterials-group
Research Disciplines
Biotechnology, Development, Stem Cells & Regeneration, Neuroimmunology, Neuroscience
Research Interests
Neural tissue engineering, biomaterials, drug delivery, redox regulation of stem cell fate, engineering cell-interactive microenvironments
Research Description
Neural regeneration within the central nervous system (CNS) is a critical unmet challenge as CNS disorders continue to be the leading cause of disability nationwide. Engineers can provide a unique perspective in the design and development of materials for human health to help effectively translate them to the clinic. We propose an innovative combination of biomaterial-cell interactions drawing on aspects of engineering, stem cell biology, and neuroscience with a unifying theme of functional neural tissue engineering. Our overarching goal is to develop a new, integrated approach in building material systems that are both cell-instructive and cell-responsive, creating a dynamic feedback loop between a cell and its engineered microenvironment. Promising opportunities for discovery exist at the intersection of biomaterials, stem cells, and reactive oxygen species, and we anticipate combining them to cut a unique path as neural engineers.
New material platforms for neural tissues that can direct neural tissue maturation and function.
We are designing hydrogel materials using both synthetic polymer and recombinant protein strategies to recapitulate the neural stem cell niche and induce dynamic cell-material interactions. The problem of axon regeneration is far from being solved, but axons can extend over long distances in vitro and in vivo by using innovative combinations of tunable materials and physical architecture. While growth is a critical step in neural regeneration, a therapy is only obtained when these axon projections function correctly in signal transmission. We encapsulate both neurons and oligodendrocytes, the cells responsible for myelination of functional axons, and control the growth of each cell type in a tunable 3D environment to begin to recapitulate functional interactions.
Localized and controlled delivery of factors important to cell survival and function.
Delivery of protein therapeutics has been a target for neural regeneration in a host of CNS diseases and injuries including Parkinson's, Alzheimer's, spinal cord injury, and stroke, but their targeted, sustained delivery is a challenge to translational medicine due to fast clearance from the target site or degradation within a couple hours of delivery. We incorporate methods for spatial and temporal control of small molecule and large protein delivery via both passive diffusion and active, cell-controlled mechanisms.
Regulating cellular reduction/oxidation to influence stem cell survival, self-renewal, and differentiation in a tissue-like environment.
We are bringing an engineer's perspective to questions of redox biology. While disregulation of native reactive oxygen species (ROS)-scavenging enzymes within the cell is linked to a variety of disorders including Parkinson's and Alzheimer's disease, it is increasingly recognized that redox regulation within a cell is a critical signaling mechanism for cellular processes including survival, proliferation, differentiation, and cell motility. In a controlled hydrogel culture system we are harnessing the power of degradable materials to elucidate novel understandings of oxidant and antioxidant effects of biomaterials on cells, to manipulate the redox balance of encapsulated cells, and to positively bias cell fate. We hope that by modulating ROS insults in vivo and providing a permissive environment for transplanted cells by using a ROS-scavenging material, we may decrease secondary injury and greatly improve the efficacy of transplant cell therapy.